DNA Sequencing Market to Grow with a CAGR of 20.53% through 2030
Increasing
government initiatives to promote genomic research and the growing demand for
precision medicine, is expected to drive the Global DNA Sequencing Market
growth in the forecast period, 2026-2030
According to
TechSci Research report, “DNA Sequencing Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global DNA Sequencing Market stood at USD
15.22 Billion in 2024 and is expected to reach USD 46.72 Billion by
2030 with a CAGR of 20.53% during the forecast period. The Global DNA
Sequencing Market is evolving rapidly, driven by innovations in sequencing
technologies and their expanding use in clinical and research applications.
Advances in high-throughput sequencing, particularly in next-generation and
third-generation sequencing, have made it possible to sequence entire genomes
faster, cheaper, and with higher accuracy. These improvements have enabled DNA
sequencing to be more accessible, leading to its broader integration into
diagnostics, treatment planning, and research initiatives. The growing
importance of understanding genetic makeup has made sequencing tools crucial
for drug discovery, biomarker development, and personalized healthcare
applications. The shift towards more cost-effective and scalable sequencing
methods is expected to fuel further adoption across a range of industries,
including pharmaceuticals, biotechnology, and healthcare.
Several factors
are accelerating the growth of the DNA sequencing market, including the rising
global focus on genomics and its role in enhancing medical research. The
increased emphasis on precision medicine, where therapies are customized based
on genetic information, is expanding the scope of DNA sequencing. As healthcare
systems focus on individualized treatments for complex diseases such as cancer
and genetic disorders, the demand for genetic testing and sequencing
technologies has grown significantly. In addition, there is increasing
awareness among healthcare professionals and patients about the potential
benefits of genomics in disease prevention, diagnosis, and management, driving
further adoption of DNA sequencing technologies in clinical settings.
As the demand
for personalized medicine continues to rise, significant growth opportunities
exist for DNA sequencing in emerging applications such as liquid biopsy for
cancer detection, genetic testing for rare diseases, and pharmacogenomics.
Additionally, advancements in artificial intelligence and machine learning are
expected to enhance the efficiency of sequencing data analysis, opening new
doors for faster and more accurate diagnostics. The integration of sequencing
technologies with other medical devices and health platforms, such as wearable
health trackers and remote diagnostics, presents new growth avenues. These
innovations in DNA sequencing will likely transform healthcare delivery and
improve patient outcomes, offering substantial opportunities for stakeholders
across the market.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global DNA Sequencing Market”
The Global DNA
Sequencing Market is segmented into product type, technology, application, end
user, regional distribution, and company.
Based on the Technology,
Third-Generation Sequencing emerged as the fastest growing segment in the Global
DNA Sequencing Market during the forecast period. This is due to its ability to
offer faster, more accurate, and cost-effective sequencing solutions compared
to traditional and second-generation sequencing technologies. Third-generation
sequencing, which includes technologies like single-molecule real-time (SMRT)
sequencing and nanopore sequencing, allows for long-read sequencing, enabling
researchers to obtain more comprehensive and accurate genomic data. This
capability is crucial for studying complex genomic regions, structural
variations, and repetitive sequences, which are often challenging for other
sequencing methods. The increasing demand for high-throughput sequencing,
combined with the need for improved resolution in genetic research, has
significantly driven the adoption of third-generation sequencing technologies.
These technologies also offer the advantage of direct DNA sequencing,
eliminating the need for amplification, which reduces errors and improves the
overall accuracy of sequencing. The ability to perform real-time sequencing
with minimal sample preparation is another key factor contributing to the rapid
growth of third-generation sequencing.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
DNA Sequencing Market during
the forecast period. This is due to a combination of factors, including rapid
advancements in healthcare infrastructure, increasing investments in genomics
research, and the rising demand for personalized medicine. Countries like
China, India, Japan, and South Korea are witnessing significant growth in
biotechnology and healthcare sectors, contributing to the adoption of DNA
sequencing technologies. Governments in the region are actively supporting
genomics research through funding, initiatives, and collaborations with global
organizations, which is accelerating the development and application of DNA
sequencing in various sectors. The rising prevalence of genetic disorders,
cancer, and chronic diseases in Asia-Pacific has fueled the demand for more
accurate diagnostic and therapeutic solutions, which in turn drives the
adoption of DNA sequencing in clinical settings. Additionally, the growing trend
of precision medicine, which uses genetic data to tailor treatments to
individual patients, is gaining momentum in the region. The cost-effectiveness
and scalability of DNA sequencing technologies, especially with the rise of
Next-Generation Sequencing (NGS), are also making them more accessible to
healthcare providers and researchers in developing economies. As
more institutions and healthcare systems in Asia-Pacific embrace genomic
technologies, the region is expected to continue its rapid growth in the DNA
sequencing market, driven by increasing healthcare investments, rising demand
for personalized treatments, and technological advancements.
Major
companies operating in Global DNA Sequencing Market are:
- Thermo
Fisher Scientific Inc.
- Agilent
Technologies, Inc.
- Bio-Rad
Laboratories, Inc.
- F.
Hoffmann-La Roche Ltd.
- Illumina,
Inc.
- QIAGEN
N.V.
- Merck
KGaA
- Macrogen,
Inc.
- PerkinElmer,
Inc.
- Eurofins
Scientific Limited
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global DNA Sequencing Market is
expanding due to the increasing use of sequencing technologies in rare disease
diagnosis. Advances in DNA sequencing enable the identification of genetic
mutations and variations that may cause rare or undiagnosed diseases. The
ability to pinpoint specific genetic factors driving rare conditions is crucial
for accurate diagnosis and the development of targeted therapies. This trend is
driving demand for more precise, affordable, and faster sequencing solutions,
which in turn is accelerating market growth. As genetic testing becomes a
critical tool for diagnosing a wider range of conditions, especially in
pediatric and neonatal healthcare, the market is poised for significant
expansion.,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“DNA Sequencing Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By
Product Type (Instruments, Consumables, Services), By Technology (Sanger
Sequencing, Next-Generation Sequencing (NGS), Third-Generation Sequencing,
Others), By Application (Diagnostics, Research, Personalized Medicine, Forensic
Testing, Others), By End User (Hospitals and Healthcare Organizations,
Academics and Research Institutions, Pharmaceutical and Biotechnology
Companies, Others), By Region and Competition, 2020-2030F”,
has evaluated the future growth potential of Global DNA Sequencing Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global DNA Sequencing Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com